Revanesse Versa in Brandon, FL
REVANESSE VERSA
Revanesse Versa: Elevate Your Look with Advanced Dermal Filler Technology
Revanesse Versa is an innovative, FDA-approved dermal filler made from cross-linked hyaluronic acid that enhances facial volume to smooth, plump, and contour the skin. Most commonly used to treat pronounced facial lines, this versatile filler helps restore youthful contours and addresses common signs of aging. Since its launch in 2012, more than 3 million syringes have been sold worldwide, making it a trusted solution for those seeking effective, long-lasting results.
The Versa Difference
Revanesse Versa stands out for its minimally invasive treatment approach that delivers immediate results with virtually no downtime. What sets the Revanesse family of fillers apart is their high level of refinement and quality. With a high viscosity (thickness), these fillers are exceptionally versatile and durable. Versa’s advanced manufacturing process creates spherical particles, allowing the formula to integrate more naturally into the body. This unique design minimizes swelling and leads to longer-lasting results as the filler breaks down more slowly within the body.
Frequently Asked Questions
Q: How long do Revanesse Versa results last?
A: Results from Revanesse Versa can last up to one year, making it an excellent option for long-lasting facial enhancement.
Q: Which is better for treating laugh lines—Revanesse Versa or Juvéderm?
A: Both Revanesse Versa and Juvéderm are effective options for treating laugh lines. However, Versa is often preferred because it tends to last longer, as Juvéderm breaks down more quickly in the body.
Q: What areas can be treated with Revanesse Versa?
A: Revanesse Versa is versatile and can be used to treat a variety of facial areas, including under the eyes, the bridge of the nose, the chin, jawline, and cheeks.
Q: How much does Revanesse Versa typically cost?
A: The cost of Revanesse Versa starts at approximately $650 per syringe, though pricing may vary depending on individual treatment needs.